tiprankstipranks
Trending News
More News >

Mike Davis to become CDER deputy director, Pink Sheet’s Gingery says

Derrick Gingery of pharma-focused publication Pink Sheet, reported on X: “Breaking: The @US_FDA ‘s CDER announces Mike Davis, former team leader in the FDA Division of Psychiatry and current Usona Institute CMO, will become CDER deputy director.” Publicly-traded companies in the psychiatric drug space include atai Life Sciences (ATAI), Clearmind (CMND), Compass Pathways (CMPS), Cybin (CYBN), GH research (GHRS) and Mind Medicine (MNMD).

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1